Inactive Instrument

DOXA AKTI Share Price Swiss Exchange

Equities

SE0005624756

Real Estate Development & Operations

End-of-day quote Swiss Exchange
- SEK - Intraday chart for DOXA AKTI

Financials

Sales 2022 5.3M 504K 42M Sales 2023 9.9M 941K 78.46M Capitalization 1.74B 166M 13.81B
Net income 2022 -39M -3.71M -309M Net income 2023 292M 27.74M 2.31B EV / Sales 2022 259 x
Net cash position 2022 52.1M 4.95M 413M Net Debt 2023 94.6M 8.99M 750M EV / Sales 2023 186 x
P/E ratio 2022
-34.2 x
P/E ratio 2023
4.52 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 49.25%
More Fundamentals * Assessed data
Doxa AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Doxa AB announced that it has received SEK 200 million in funding CI
Doxa AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Doxa AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Balder, Doxa Portfolio Company Sell Building Rights in Sweden for SEK1 Billion MT
Doxa AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Valsoia creates new market segment with first liquid vegetable egg AN
Doxa AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Doxa AB (OM:DOXA) completed the acquisition of Serneke Group AB (OM:SRNKE B) from Ola Serneke Invest AB, Fastighets AB Balder (OM:BALD B), Svolder AB (OM:SVOL B) and other shareholders. CI
When the narrative is stronger than fundamentals on stock markets Our Logo
Doxa AB Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Serneke Receives Public Takeover Offer From Doxa MT
Doxa AB (OM:DOXA) made an offer to acquire Serneke Group AB (OM:SRNKE B) from Ola Serneke Invest AB, Fastighets AB Balder (OM:BALD B), Svolder AB (OM:SVOL B) and other shareholders for SEK 1 billion. CI
Doxa AB Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Doxa AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
More news
Managers TitleAgeSince
Chief Executive Officer 40 01/22/01
Director of Finance/CFO 47 01/22/01
Members of the board TitleAgeSince
Director/Board Member 64 01/21/01
Director/Board Member 53 01/23/01
Chairman 53 01/21/01
More insiders
Doxa AB is a Sweden-based company which develops products based on bio-active ceramics. The Company develops, manufactures and commercializes products based upon its technology platform of calcium aluminate hydrate and bioactive ceramics. Activities are divided into the therapy areas of orthopedics and odontology. Research areas within orthopedics are methods for treating fractures resulting from osteoporosis, reconstructive orthopedics and coating of implants. Research areas within odontology are tooth restoration and implant fixation.
More about the company